Àngels Arcusa

Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled Trial

Francisco Rodríguez‐Moranta, Joan Saló, Àngels Arcusa et al. · Journal of Clinical Oncology · 2005 · 297 citations

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón et al. · New England Journal of Medicine · 2010 · 208 citations · Full text

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

Miguel Martín, Aňa Lluch, Miguel Ángel Seguí et al. · Annals of Oncology · 2006 · 204 citations · Full text

Breast Oncology, Breast Cancer Patients, Medicine +8

Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer

Luis Cirera, A. Balil, E. Batiste-Alentorn et al. · Journal of Clinical Oncology · 1999 · 115 citations

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

Aleix Prat, Aňa Lluch, Joan Albanell et al. · British Journal of Cancer · 2014 · 110 citations · Full text